• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性表皮松解症儿童和成人的足病评估:足踝患者报告结局量表(PROMs)能否衡量大疱性表皮松解症(EB)患者足部受累的严重程度?

Podiatric assessment in children and adults with epidermolysis bullosa: are foot and ankle patient-reported outcome measures (PROMs) able to measure the severity of podiatric involvement among EB patients?

作者信息

Wong Joy Lynn, Khan Mohammed Tariq, Cowan Timothy L, Murrell Dedée F

机构信息

Faculty of Medicine, University of New South Wales, High Street, Kensington NSW, Sydney, Australia.

Department of Dermatology, St George Hospital, Gray Street, Kogarah NSW, Sydney, Australia.

出版信息

Int J Womens Dermatol. 2023 Jan 19;9(1):e046. doi: 10.1097/JW9.0000000000000046. eCollection 2023 Mar.

DOI:10.1097/JW9.0000000000000046
PMID:36700162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9851710/
Abstract

Epidermolysis bullosa (EB) represents a group of rare genetic skin fragility disorders characterized by (muco) cutaneous blistering upon minimal mechanical trauma. Ninety percent of EB patients experience podiatric symptoms which may affect physical functioning and emotional well-being. To date, an EB-specific podiatric assessment has not been outlined to guide clinicians in the assessment of EB podiatric involvement. This review describes the podiatric involvement of patients with EB and assesses the relevance of validated foot and ankle patient-reported outcome measures (PROMs) in measuring podiatric severity among EB patients. A literature review was conducted to identify systematic reviews and clinical studies investigating foot health and podiatric manifestations using validated foot health PROMs across foot and ankle conditions. Limited studies have documented the significance of podiatric involvement among EB patients. Existing EB-specific PROMs are not region-specific for assessing podiatric involvement. Among the foot and ankle PROMs, the Foot Health Status Questionnaire, Foot Function Index, and Manchester Oxford Foot Questionnaire were identified as potentially appropriate for assessing podiatric severity among EB patients, each with its strengths and limitations in assessment. However, they have not been widely validated for assessing dermatology-related diseases. An evaluation of the relevance of each identified PROM to EB podiatric assessment would enable future development of an appropriate EB-specific podiatric assessment tool that would guide management.

摘要

大疱性表皮松解症(EB)是一组罕见的遗传性皮肤脆性疾病,其特征是在受到最小程度的机械创伤后出现(黏液)皮肤水疱。90%的EB患者会出现足部症状,这可能会影响身体功能和情绪健康。迄今为止,尚未概述针对EB的足部评估方法,以指导临床医生评估EB患者的足部受累情况。本综述描述了EB患者的足部受累情况,并评估了经过验证的足踝患者报告结局量表(PROMs)在衡量EB患者足部严重程度方面的相关性。进行了一项文献综述,以确定使用经过验证的足部健康PROMs对足踝状况进行足部健康和足部表现调查的系统评价和临床研究。有限的研究记录了EB患者足部受累的重要性。现有的针对EB的PROMs在评估足部受累方面并非区域特异性的。在足踝PROMs中,足部健康状况问卷、足部功能指数和曼彻斯特牛津足部问卷被确定为可能适用于评估EB患者足部严重程度的量表,每个量表在评估中都有其优点和局限性。然而,它们尚未被广泛验证用于评估皮肤病相关疾病。对每种已确定的PROM与EB足部评估的相关性进行评估,将有助于未来开发一种合适的针对EB的足部评估工具,以指导治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b323/9851710/5e59a06b6dd8/jw9-9-e046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b323/9851710/797a11ff2c56/jw9-9-e046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b323/9851710/5e59a06b6dd8/jw9-9-e046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b323/9851710/797a11ff2c56/jw9-9-e046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b323/9851710/5e59a06b6dd8/jw9-9-e046-g002.jpg

相似文献

1
Podiatric assessment in children and adults with epidermolysis bullosa: are foot and ankle patient-reported outcome measures (PROMs) able to measure the severity of podiatric involvement among EB patients?大疱性表皮松解症儿童和成人的足病评估:足踝患者报告结局量表(PROMs)能否衡量大疱性表皮松解症(EB)患者足部受累的严重程度?
Int J Womens Dermatol. 2023 Jan 19;9(1):e046. doi: 10.1097/JW9.0000000000000046. eCollection 2023 Mar.
2
Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.工具评分的临床结局研究的表皮松解症患者评分(iscorEB-p)的心理测量特性:一种患者报告的结局测量。
Br J Dermatol. 2024 Jun 20;191(1):75-81. doi: 10.1093/bjd/ljae019.
3
Podiatric management in epidermolysis bullosa.大疱性表皮松解症的足部医学管理。
Dermatol Clin. 2010 Apr;28(2):325-33, x-xi. doi: 10.1016/j.det.2010.02.006.
4
A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.慢性皮肤大疱性疾病眼受累评分系统的研究进展。
Orphanet J Rare Dis. 2018 May 22;13(1):83. doi: 10.1186/s13023-018-0823-5.
5
Creating new guidelines on how best to treat foot symptoms in people with EB.制定关于如何最佳治疗大疱性表皮松解症患者足部症状的新指南。
Br J Dermatol. 2020 Mar;182(3):e89-e114. doi: 10.1111/bjd.18820.
6
Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research tool.大疱性表皮松解症研究临床结局评分工具:一种通过共识产生的临床研究工具。
Pediatr Dermatol. 2015 Jan-Feb;32(1):41-52. doi: 10.1111/pde.12317. Epub 2014 Mar 20.
7
Epidermolysis Bullosa: Pediatric Perspectives.大疱性表皮松解症:儿科视角。
Curr Pediatr Rev. 2022;18(3):182-190. doi: 10.2174/1573396317666210525161252.
8
Homocysteine metabolism in children and adolescents with epidermolysis bullosa.患有大疱性表皮松解症的儿童和青少年的同型半胱氨酸代谢
BMC Pediatr. 2016 Oct 29;16(1):173. doi: 10.1186/s12887-016-0714-7.
9
Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.遗传性大疱性表皮松解症皮肤护理的多中心共识建议。
Orphanet J Rare Dis. 2014 May 20;9:76. doi: 10.1186/1750-1172-9-76.
10
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB).大疱性表皮松解症结局指标的比较研究:大疱性表皮松解症疾病活动与瘢痕指数(EBDASI)和大疱性表皮松解症研究临床结局评分工具(iscorEB)。
JAAD Int. 2021 Jan 21;2:134-152. doi: 10.1016/j.jdin.2020.12.007. eCollection 2021 Mar.

本文引用的文献

1
Measures of Foot Pain, Foot Function, and General Foot Health.足部疼痛、足部功能及足部整体健康的测量指标。
Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:294-320. doi: 10.1002/acr.24208.
2
Evaluation of Validity, Reliability, and Feasibility of 3 Patient-Reported Foot and Ankle Outcome Measures.3 种患者报告的足部和踝关节结局测量工具的有效性、信度和可行性评估。
J Foot Ankle Surg. 2020 May-Jun;59(3):507-512. doi: 10.1053/j.jfas.2019.09.033.
3
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.
遗传性大疱性表皮松解症及其他皮肤脆性疾病的共识性重新分类
Br J Dermatol. 2020 Oct;183(4):614-627. doi: 10.1111/bjd.18921. Epub 2020 Mar 11.
4
Podiatrists gaining a foothold.足病医生正在站稳脚跟。
Br J Dermatol. 2020 Mar;182(3):527-528. doi: 10.1111/bjd.18614. Epub 2019 Nov 20.
5
Foot care in epidermolysis bullosa: evidence-based guideline.大疱性表皮松解症的足部护理:循证指南
Br J Dermatol. 2020 Mar;182(3):593-604. doi: 10.1111/bjd.18381. Epub 2019 Oct 23.
6
The impact of multimorbidity on foot health outcomes in podiatry patients with musculoskeletal foot pain: a prospective observational study.多病症对肌肉骨骼足部疼痛的足病患者足部健康结果的影响:一项前瞻性观察研究。
J Foot Ankle Res. 2019 Jul 3;12:36. doi: 10.1186/s13047-019-0346-x. eCollection 2019.
7
Systematic review of the psychometric properties of patient-reported outcome measures for rheumatoid arthritis in the foot and ankle.系统评价足部和踝关节类风湿关节炎患者报告结局测量的心理测量特性。
Clin Rehabil. 2019 Nov;33(11):1788-1799. doi: 10.1177/0269215519862328. Epub 2019 Jul 10.
8
Patient-Reported Outcome Measures for Patients with Diabetes Mellitus Associated with Foot and Ankle Pathologies: A Systematic Review.糖尿病合并足踝病变患者的患者报告结局指标:一项系统评价
J Clin Med. 2019 Jan 27;8(2):146. doi: 10.3390/jcm8020146.
9
Patient-reported outcome measures in osteoarthritis: a systematic search and review of their use and psychometric properties.骨关节炎患者报告的结局指标:对其应用及心理测量特性的系统检索与综述
RMD Open. 2018 Dec 16;4(2):e000715. doi: 10.1136/rmdopen-2018-000715. eCollection 2018.
10
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.评估北美的大疱性表皮松解症患者里程碑临床事件的发生时间。
JAMA Dermatol. 2019 Feb 1;155(2):196-203. doi: 10.1001/jamadermatol.2018.4673.